- Home
- OCX vs LRE Comparison
OCX vs LRE Comparison
Compare OCX & LRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCX
- LRE
- Stock Information
- Founded
- OCX 2009
- LRE 2001
- Country
- OCX United States
- LRE Japan
- Employees
- OCX N/A
- LRE N/A
- Industry
- OCX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- LRE
- Sector
- OCX Health Care
- LRE
- Exchange
- OCX Nasdaq
- LRE Nasdaq
- Market Cap
- OCX 35.1M
- LRE 29.9M
- IPO Year
- OCX N/A
- LRE 2023
- Fundamental
- Price
- OCX $2.08
- LRE $1.76
- Analyst Decision
- OCX Buy
- LRE
- Analyst Count
- OCX 3
- LRE 0
- Target Price
- OCX $4.42
- LRE N/A
- AVG Volume (30 Days)
- OCX 69.1K
- LRE 18.7K
- Earning Date
- OCX 11-12-2024
- LRE 01-01-0001
- Dividend Yield
- OCX N/A
- LRE N/A
- EPS Growth
- OCX N/A
- LRE N/A
- EPS
- OCX N/A
- LRE 0.29
- Revenue
- OCX $709,000.00
- LRE $117,804,154.00
- Revenue This Year
- OCX N/A
- LRE N/A
- Revenue Next Year
- OCX $106.34
- LRE N/A
- P/E Ratio
- OCX N/A
- LRE $6.04
- Revenue Growth
- OCX N/A
- LRE 8.82
- 52 Week Low
- OCX $1.97
- LRE $1.19
- 52 Week High
- OCX $3.48
- LRE $13.76
- Technical
- Relative Strength Index (RSI)
- OCX 37.86
- LRE 43.68
- Support Level
- OCX $2.05
- LRE $1.68
- Resistance Level
- OCX $2.24
- LRE $2.08
- Average True Range (ATR)
- OCX 0.21
- LRE 0.15
- MACD
- OCX -0.00
- LRE 0.00
- Stochastic Oscillator
- OCX 15.28
- LRE 41.41
About OCX Oncocyte Corporation
OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers. In addition, it also develops screening diagnostics as potential replacements for screening imaging procedures that do not meet the needs of patients, health care providers or payers.
About LRE Lead Real Estate Co. Ltd
Lead Real Estate Co Ltd operates as a developer of luxury residential properties, including single-family homes and condominiums, across Tokyo, Kanagawa prefecture, and Sapporo. The company also operates hotels in Tokyo and leases apartment building units to individual customers in Japan and Dallas, Texas. Predominantly, its revenue is generated from developing and selling single-family homes and condominiums. The company's sole operating segment is real estate sales. Geographically, it derives revenue from Japan.